PMS10 THE COST-EFFECTIVENESS OF ABATACEPT VERSUS RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS- A PERSPECTIVE OF THE CANADIAN PUBLICLY FUNDED HEALTH CARE SYSTEM
May 1, 2008, 00:00
10.1016/S1098-3015(10)70812-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70812-3/fulltext
Title :
PMS10 THE COST-EFFECTIVENESS OF ABATACEPT VERSUS RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS- A PERSPECTIVE OF THE CANADIAN PUBLICLY FUNDED HEALTH CARE SYSTEM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70812-3&doi=10.1016/S1098-3015(10)70812-3
First page :
Section Title :
Open access? :
No
Section Order :
563